StonvexLoading…
StonvexStonvexStonvexCore line items from AGCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.81B | $2.34B | $10.08B | $7.16B | $4.69B |
Operating Income | Not available | $80.70M | $595.70M | $365.00M | $213.40M |
Net Income | Not available | $55.00M | $726.50M | $631.00M | $325.30M |
EPS (Diluted) | $1.48 | $0.76 | $9.75 | $8.45 | $4.36 |
Total Assets | Not available | $12.04B | $11.93B | $12.47B | $12.31B |
Total Liabilities | Not available | $7.45B | $7.36B | $7.67B | $7.84B |
Cash & Equivalents | Not available | $514.90M | $861.80M | $884.10M | $783.90M |
Free Cash Flow OCF − CapEx | Not available | $-455.00M | $740.20M | $65.20M | $63.10M |
Shares Outstanding | Not available | 72.40M | 72.63M | 74.62M | 74.60M |